Matrix Metalloproteinases's in Oral Biofluids During Pregnancy and Postpartum
Modulation of Matrix Metalloproteinases-8, -9 and Endogenous Tissue Inhibitor-1 in Oral Biofluids During Pregnancy and Postpartum
1 other identifier
observational
114
0 countries
N/A
Brief Summary
The aim of this study was to investigate salivary and gingival crevicular fluid (GCF) levels of MMP-8, MMP-9 and TIMP-1 during 2/3 trimester of pregnancy and after delivery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2013
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 24, 2018
CompletedFirst Posted
Study publicly available on registry
May 4, 2018
CompletedMay 4, 2018
April 1, 2018
1.5 years
April 24, 2018
April 24, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Changing MMP-8 levels
Salivary and GCF level measured by IFMA
6 months
Changing MMP-9 levels
Salivary and GCF level measured by ELISA
6 months
Changing TIMP-1 levels
Salivary and GCF level measured by ELISA
6 months
Study Arms (3)
Pregnancy group
Pregnant group included women, who were in their second trimester (weeks 16-24) and third trimester (weeks 25-34)
Postpartum group
Postpartum group included women, who were evaluated 6 months after giving birth
Non-pregnant group
Women who were systemically healthy and non-pregnant.
Interventions
Eligibility Criteria
All women were systemically healthy
You may qualify if:
- Pregnant group included women, who were in their second trimester (weeks 16-24) and third trimester (weeks 25-34)
You may not qualify if:
- (a) any known systemic disease, (b) periodontal treatment within the last six months, (c) patients having less than 10 teeth, (d) smokers and (e) individuals with BMI \> 30 kg/m2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 24, 2018
First Posted
May 4, 2018
Study Start
April 1, 2013
Primary Completion
October 15, 2014
Study Completion
September 1, 2015
Last Updated
May 4, 2018
Record last verified: 2018-04
Data Sharing
- IPD Sharing
- Will not share